Insulin treatment in children with type one diabetes

Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie
J Beltrand, J-J Robert

Abstract

In all age groups, the aim of insulin treatment will be as close to physiological insulin replacement as possible in order to obtain optimum metabolic control. Rapid and long acting insulin analogs represent some improvement in the care of diabetes in children by improving glycaemic control and decreasing the occurrence of hypoglycaemia. Insulin dosage will be determined to allow appropriate insulin levels throughout the twenty-four hours to cover basal requirements and higher levels of insulin in an attempt to match the glycaemic effect of meals. The distribution of insulin dose across the days shows great individual variations and daily insulin dosage varies greatly between individuals end changes over time. Regardless of mode of insulin therapy, doses should be adapted based on the daily pattern of blood glucose and therefore require regular review and assessment. The device used for insulin administration must be adapted for paediatric patients. Whatever insulin regimen is chosen it must be supported by comprehensive education adapted for the age, maturity and individual needs of the child and family.

References

Jul 1, 1991·Archives of Disease in Childhood·C P SmithD A Price
Dec 1, 1994·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·B H GinsbergC Sparacino
Jan 6, 1994·The New England Journal of Medicine·M BojestigJ Ludvigsson
Sep 13, 2001·Diabetic Medicine : a Journal of the British Diabetic Association·S TupolaI Sipilä
May 23, 2002·Clinical Therapeutics·John H HolcombeUNKNOWN Lispro in Adolescents Study Group
Sep 3, 2004·The Journal of Pediatrics·Linda A DiMeglioErica A Eugster
Jan 18, 2007·Diabetic Medicine : a Journal of the British Diabetic Association·K J RobertsonJ Ludvigsson
May 28, 2008·Pediatric Diabetes·M A BerghaeuserUNKNOWN German working group for insulin pump treatment in paediatric patients
Jan 23, 2009·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Paul C DavidsonBruce W Bode

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.